英文名稱 |
中文名稱 |
CAS號(hào) |
操作 |
Naphthoic Acid Impurity 16 |
4-(2,4-Dichloro-5-Methoxyphenoxy)aniline |
125138-50-3 |
詳細(xì)
|
Naphthoic Acid Impurity 12 |
羥基二氯二苯醚 |
3380-30-1 |
詳細(xì)
|
Acipimox Impurity 4 |
丙戊酸-D6 |
87745-18-4 |
詳細(xì)
|
Palbociclib Impurity 32 |
|
946517-40-4 |
詳細(xì)
|
Palbociclib Impurity 30 |
3-KETOVALPROIC ACID SODIUM SALT |
1184991-15-8 |
詳細(xì)
|
Naphthoic Acid Impurity 21 |
比索洛爾EP雜質(zhì)C |
1797132-90-1 |
詳細(xì)
|
Midazolam Impurity 15 |
3-乙氧基-4-甲氧基苯甲醛 |
1131-52-8 |
詳細(xì)
|
Warfarin Impurity 38 |
N-(1-氧代戊基)-N-[[2'-(1H-四唑-5-基)[1,1'-聯(lián)苯]-4-基]甲基]-L-丙氨酸 |
137862-57-8 |
詳細(xì)
|
Linagliptin Impurity 49 |
苯并[C]異惡唑-3(1H)-酮 |
31499-90-8 |
詳細(xì)
|
1-Naphthoic Acid |
7-甲氧基-2-萘甲酸 |
5043-07-2 |
詳細(xì)
|
Naphthoic Acid Impurity 8 |
6-甲基-1-萘甲酸 |
6315-19-1 |
詳細(xì)
|
Acetylcysteine Impurity 59 |
硫培南 |
120788-07-0 |
詳細(xì)
|
Warfarin Impurity 31 |
纈沙坦雜質(zhì)60 |
1894176-48-7 |
詳細(xì)
|
Palbociclib Impurity 135 |
sodium:5-hydroxy-2-propylpentanoate |
78644-53-8 |
詳細(xì)
|
Naphthoic Acid Impurity 18 |
DICLOFOP |
61955-11-1 |
詳細(xì)
|
Cefuroxime Impurity 73 |
纈沙坦雜質(zhì)22 |
1089736-73-1 |
詳細(xì)
|
Palbociclib Impurity 134 |
RAC 5-羥基丙戊羧酸鈉鹽 |
53660-23-4 |
詳細(xì)
|
Valacyclovir-d4 Hydrochloride |
鹽酸伐昔洛韋-d4 |
1331910-75-8 |
詳細(xì)
|
Warfarin Impurity 39 |
纈沙坦異丙酯 |
1245820-09-0 |
詳細(xì)
|
Valproic Acid Impurity 17 |
4-氨基鄰苯二甲酸 |
5434-21-9 |
詳細(xì)
|
Warfarin Impurity 27 |
4-羥基纈紗坦芐酯 |
1356929-45-7 |
詳細(xì)
|
Valacyclovir Impurity 30 |
伐昔洛韋雜質(zhì)30 |
1356350-92-9 |
詳細(xì)
|
Lysine Acetylsalicylate Impurity 14 |
3-羥基辛烷-4-甲酸 |
58888-84-9 |
詳細(xì)
|
Posaconazole Impurity 149 |
禾草靈 |
40843-25-2 |
詳細(xì)
|
Naphthoic Acid Impurity 14 |
(2R)-2-[4-(2,4-二氯苯氧基)苯氧基]丙酸甲酯 |
71283-65-3 |
詳細(xì)
|
Linagliptin Impurity 116 |
乙酰半胱氨酸雜質(zhì)58 |
169553-06-4 |
詳細(xì)
|
Tranexamic Acid Impurity 24 |
阿拉普利 |
74258-86-9 |
詳細(xì)
|
Naphthoic Acid Impurity 5 |
4-氰基-1-萘酸 |
3839-19-8 |
詳細(xì)
|
Warfarin Impurity 36 |
PJGGEFUAFDAJJT-CJQVKMEYSA-N |
1246815-65-5 |
詳細(xì)
|
Naphthoic Acid Impurity 4 (2-Naphthoic Acid) |
6-甲氧基萘甲酸 |
36112-61-5 |
詳細(xì)
|
Carisoprodol Impurity 10 |
阿義嗎啉 |
4360-12-7 |
詳細(xì)
|
Naphthoic Acid Impurity 13 |
|
71283-28-8 |
詳細(xì)
|
Posaconazole Impurity 148 |
6-羥基-1-萘甲酸 |
2437-17-4 |
詳細(xì)
|
Naphthoic Acid Impurity 17 |
1,5-Dichloro-2-Methoxy-4-(4-nitrophenoxy)benzene |
125138-49-0 |
詳細(xì)
|
Warfarin Impurity 35 |
丙戊酸-D4 |
87745-17-3 |
詳細(xì)
|
Avibactam Impurity 67 |
阿地普林 |
56066-63-8 |
詳細(xì)
|
Linagliptin Impurity 92 |
(H-CYS-BETANA)2 2 HCL |
100900-22-9 |
詳細(xì)
|
Naphthoic Acid Impurity 15 |
禾草靈-5-羥基 |
124992-48-9 |
詳細(xì)
|
Posaconazole Impurity 150 |
禾草靈 |
51338-27-3 |
詳細(xì)
|
Warfarin Impurity 37 |
KAZCQVXZLKDFCA-NDEPHWFRSA-N |
1798904-61-6 |
詳細(xì)
|
Mitoxantrone Impurity 14 |
7-(芐氧基)-8-甲氧基異色烷-3-酮 |
65615-23-8 |
詳細(xì)
|
Acipimox Impurity 3 |
(1S,3S,5S)-2-氮雜雙環(huán)[3.1.0]己烷-3-甲腈 |
866083-42-3 |
詳細(xì)
|
Nicotinic Acid Impurity 22 |
sodium:3,3,4,4,5,5,5-heptadeuterio-2-(3-hydroxypropyl)pentanoate |
1189994-89-5 |
詳細(xì)
|
Palbociclib Impurity 46 |
Valproic Acid b-D-Glucuronide |
60113-83-9 |
詳細(xì)
|
Naphthoic Acid Impurity 19 |
5-Hydroxynitrofen |
63987-04-2 |
詳細(xì)
|
Naphthoic Acid Impurity 6 |
5-氰基-1-萘酸 |
3839-20-1 |
詳細(xì)
|
Naphthoic Acid Impurity 25 |
N-羥基琥珀酰亞胺磺酸鈉鹽 |
106627-54-7 |
詳細(xì)
|
Chlorzoxazone Impurity 19 |
|
1143-45-9 |
詳細(xì)
|
Diclofop Impurity 2 |
7-amino-5-(2-fluorophenyl)-1-(trideuteriomethyl)-3H-1,4-benzodiazepin-2-one |
1217062-64-0 |
詳細(xì)
|
Diclofop Impurity 6 |
|
74723-07-2 |
詳細(xì)
|
Brexanolone Impurity 1 |
|
14328-07-5 |
詳細(xì)
|
Diclofop Impurity 1 (Diclofop-methyl) |
氨基氟硝西泮 |
34084-50-9 |
詳細(xì)
|
Eicosapentaenoic Acid Impurity 21 |
N-(6-aminohexyl)-4-morpholin-4-yl-1,8-naphthalimide |
1015244-33-3 |
詳細(xì)
|
Diclofop Impurity 3 |
3-METHYL FLUNITRAZEPAM |
74892-39-0 |
詳細(xì)
|
Naphthoic Acid Impurity 26 |
妥卡尼 |
41708-72-9 |
詳細(xì)
|
Adrenaline Impurity 29 |
呋喃天竺葵酮B |
1143-46-0 |
詳細(xì)
|
Naphthoic Acid Impurity 32 |
氟硝西泮EP雜質(zhì)C |
2512213-47-5 |
詳細(xì)
|
Diclofop Impurity 5 |
|
67739-71-3 |
詳細(xì)
|
Adrenaline Impurity 30 |
OXYPHYLLENODIOL A |
363610-30-4 |
詳細(xì)
|
Eicosapentaenoic Acid Impurity 20 |
化合物 T12372 |
1782070-22-7 |
詳細(xì)
|
Tazobactam Sodium Salt |
Acipimox-d4 |
1246816-28-3 |
詳細(xì)
|
Xylose Impurity 4 |
阿西莫司雜質(zhì)4 |
98502-96-6 |
詳細(xì)
|
2-Hydroxyethyl methacrylate |
4-甲氧基-1-萘甲酸 |
13041-62-8 |
詳細(xì)
|
*Tiotropium Bromide Impurity 15 |
4-Amino-1-hydroxy-2-naphthoic acid |
13065-87-7 |
詳細(xì)
|
Warfarin Impurity 21(6-Hydroxy Warfarin) |
去羥基華法林 |
67588-18-5 |
詳細(xì)
|
Xylulose Impurity 2 |
2-氨基-3,5-二溴吡啶 |
35486-42-1 |
詳細(xì)
|
Esomeprazole Impurity 134 |
1,4-Dihydro-1-naphthoic acid |
5111-73-9 |
詳細(xì)
|
Xanthosine Impurity 2 |
萘甲酸雜質(zhì)8 |
18012-57-2 |
詳細(xì)
|
Xylose Impurity 3 |
2-乙酰氧基-2,4-二氟苯乙酮 |
122263-03-0 |
詳細(xì)
|
Warfarin Impurity 34 |
3'-hydroxywarfarin |
124952-36-9 |
詳細(xì)
|
*Selenium(IV) Oxide |
阿西莫司 |
51037-30-0 |
詳細(xì)
|
Atracurium Impurity 5(Cisatracurium Besilate EP Impurity B) |
阿西莫司雜質(zhì)3 |
51037-31-1 |
詳細(xì)
|
Gimeracil Impurity 13 |
3-氨基-1-萘甲酸 |
32018-86-3 |
詳細(xì)
|
Xylulose-13C |
4-hydroxy-3-[2-hydroxy-3-oxo-1-(2,3,4,5,6-pentadeuteriophenyl)butyl]chromen-2-one |
1286117-65-4 |
詳細(xì)
|
Xylose Impurity 9 |
5-溴-2-氯-N-環(huán)戊胺嘧啶-4胺 |
733039-20-8 |
詳細(xì)
|
Warfarin Impurity 33 |
(R)-3'-Hydroxy Warfarin |
124997-75-7 |
詳細(xì)
|
Ioxaglic Acid |
1,2-DIHYDRO-NAPHTHOIC ACID |
16827-42-2 |
詳細(xì)
|
Xanthosine Impurity 1 |
萘甲酸雜質(zhì)6 |
35666-93-4 |
詳細(xì)
|
Tiotropium Bromide Impurity 14 |
4-乙基-1-萘甲酸 |
91902-58-8 |
詳細(xì)
|
Xylose Impurity 2 |
1,2-(2,4-二氟苯基)-2-丙烯醇乙酯 |
149809-34-7 |
詳細(xì)
|
*Tiotropium Bromide Impurity 16 |
3-氨基-4-溴-2-萘酸 |
5043-27-6 |
詳細(xì)
|
Ipratropium Bromide Impurity 23 |
3-乙氧基-2-萘甲酸 |
54245-36-2 |
詳細(xì)
|
Ponatinib HCl |
5-甲基吡嗪-2-羧酸 |
5521-55-1 |
詳細(xì)
|
Xylose Impurity 5 |
10-羥基華法林 BETA-D-葡糖苷酸 |
1007224-61-4 |
詳細(xì)
|
Xylulose Impurity 3 |
2-硝基-5-氯吡啶 |
52092-47-4 |
詳細(xì)
|
Warfarin Impurity 31 |
Dehydro Warfarin-d5 |
1346606-43-6 |
詳細(xì)
|
Warfarin Impurity 35 |
4,8-dihydroxy-3-[3-oxo-1-(2,3,4,5,6-pentadeuteriophenyl)butyl]chromen-2-one |
94820-66-3 |
詳細(xì)
|
Isosorbide Impurity 12 |
3,4-二氫萘-1-甲酸 |
3333-23-1 |
詳細(xì)
|
Xylose Impurity 1-13C |
2-(2,4-Difluorophenyl)-2-propenyl-propanedioic Acid Diethyl Ester |
159276-62-7 |
詳細(xì)
|
Xanthosine Impurity 4 |
3,5-二甲氧基-2-萘酸 |
98410-68-5 |
詳細(xì)
|
Avibactam Impurity 67 |
阿維巴坦雜質(zhì)67 |
1171080-45-7 |
詳細(xì)
|
L-Ornithine L-Aspartate Impurity 26 |
阿西莫司雜質(zhì)2 |
32046-26-7 |
詳細(xì)
|
Citalopram Impurity 18(EsCitalopram EP Impurity I) |
4-甲基-1-萘甲酸 |
4488-40-8 |
詳細(xì)
|
Pazopanib Impurity 87 |
1-氨基-2-萘甲酸 |
4919-43-1 |
詳細(xì)
|
Xylulose Impurity 5 |
頭孢呋辛酯雜質(zhì)7 |
59176-08-8 |
詳細(xì)
|
Xylose Impurity 6 |
(R)-3-氨基-2-己內(nèi)酰胺 |
28957-33-7 |
詳細(xì)
|
Warfarin Impurity 32 |
3’-Hydroxy Warfarin |
30992-81-5 |
詳細(xì)
|
Isosorbide Impurity 14 |
萘甲酸雜質(zhì)5 |
18676-29-4 |
詳細(xì)
|
Tofacitinib Impurity 17 |
3-(ACETYLAMINO)-2-NAPHTHOIC ACID |
19717-59-0 |
詳細(xì)
|
Xanthosine Impurity 5 |
2-(2,4-二氟苯基)-2-丙烯-1-醇 |
141113-36-2 |
詳細(xì)
|